Using DNA microarray analyses to elucidate the effects of genistein in androgen-responsive prostate cancer cells: Identification of novel targets
✍ Scribed by Yoko Takahashi; Jackie A. Lavigne; Stephen D. Hursting; Gadisetti V.R. Chandramouli; Susan N. Perkins; J. Carl Barrett; Thomas T.Y. Wang
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 254 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0899-1987
- DOI
- 10.1002/mc.20045
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Many studies have correlated the consumption of soy‐rich diets with a decreased risk of developing hormone‐dependent cancers, including prostate cancer. Genistein is a candidate prostate cancer preventive phytochemical found at high levels in soybean and soy foods. To better understand the molecular mechanisms underlying the beneficial effects of genistein on prostate cancer prevention, we used a DNA microarray approach to examine the effects of genistein at concentrations in the physiologic range on global gene expression patterns in androgen‐responsive cancer cells. Microarray analyses were performed on androgen‐responsive LNCaP human prostate cancer cells exposed to 0, 1, 5, or 25 μM genistein. We found a concentration‐dependent modulation of multiple cellular pathways that are important in prostate carcinogenesis. Interestingly, the androgen receptor (AR)‐mediated pathways, in particular, appeared to be modulated by genistein at the lowest concentrations. Based on these results, we propose that the regulation of AR‐mediated pathways is potentially the most relevant chemopreventive mechanism for genistein administered at physiologic levels. Published 2004 Wiley‐Liss, Inc.